|
Hematology and Hemostasis |
1965 |
Analysis of genetic variation and hemophilia traits using whole genome sequencing data |
Jill Johnsen |
|
Hematology and Hemostasis |
16887 |
Assessing genetic determinants of telomere length leveraging whole genome sequence data in the NHLBI Trans-Omics for Precision Medicine Program – breakout proposal for PRS. |
Rasika Mathias |
|
Hematology and Hemostasis |
6781 |
Assessing genetic determinants of telomere length leveraging whole genome sequence data in the NHLBI Trans-Omics for Precision Medicine Program – breakout proposal. |
Rasika Mathias |
|
Hematology and Hemostasis |
2251 |
Assessing genetic determinants of telomere length leveraging whole genome sequence data in the NHLBI Trans-Omics for Precision Medicine Program. |
Rasika Mathias |
|
Hematology and Hemostasis |
1506 |
Assessing variation in blood group genes from whole genome sequencing data |
Jill Johnsen |
|
Hematology and Hemostasis |
1507 |
Assessing variation in blood group genes from whole genome sequencing data |
Jill Johnsen |
|
Hematology and Hemostasis |
2280 |
Association of BOLA2 copy number with iron and hematologic phenotypes in TOPMed |
Alex Reiner |
|
Hematology and Hemostasis |
6282 |
Association of clonal hematopoeisis of indeterminate potential (CHIP) with genome-wide changes in DNA methylation and gene expression |
Alexander Bick |
|
Hematology and Hemostasis |
3551 |
Association of clonal hematopoiesis with cardiovascular disease |
Pradeep Natarajan |
|
Hematology and Hemostasis |
11611 |
Association of Individual-level and Neighborhood-level Socioeconomic Disadvantage with Clonal Hematopoiesis of Indeterminate Potential (CHIP) in the Women’s Health Initiative (WHI) |
Shelly-Ann Love |
